RecruitingNCT06588868

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma: an Observational Retrospective Multicenter Study

Sponsor

Fondazione Italiana Linfomi - ETS

Enrollment

400 participants

Start Date

Feb 27, 2025

Study Type

OBSERVATIONAL

Conditions

Cutaneous T Cell Lymphoma Cutaneous T-Cell Lymphoma/Mycosis Fungoides Cutaneous T-Cell Lymphoma/Sezary Syndrome

Summary

The study is designed to describe the different approaches of systemic therapies for the treatment of Cutaneous T-cell Lymphoma in real world setting.

Eligibility

Min Age: 18 Years

Inclusion Criteria6

Confirmed diagnosis of CTCL according to the EORTC 2017 update criteria1.
Age ≥18 years.
Have received first dose of a systemic therapy, lasted at least 3 months, between 1 January 2016 and 31 December 2023.
Availability of complete medical records in order to provide protocol required variables
Signed written informed consent.
Refuse to sign a written informed consent.

Locations(18)

AOU Ospedali Riuniti delle Marche - Clinica di Ematologia

Ancona, Italy

IRCCS Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia

Bari, Italy

U.O.C. Dermatologia e Venereologia Universitaria - A.O.U. Policlinico Consorziale

Bari, Italy

Policlinico S.Orsola-Malpighi - Istituto di Ematologia

Bologna, Italy

ASST Spedali Civili di Brescia - S.C. Ematologia

Brescia, Italy

A.O. Brotzu Ospedale Businco - S.C. Ematologia e CTMO

Cagliari, Italy

A.O.U. Policlinico S. Marco - U.O.C. di Ematologia

Catania, Italy

Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi

Florence, Italy

S.C. Dermatologia - E.O. Galliera

Genova, Italy

Oncoematologia - ASST Fatebenefratelli - Sacco

Milan, Italy

U.O.C. Dermatologia - Ospedale Maggiore Policlinico Fondazione IRCCS Ca' Granda

Milan, Italy

U.O.C. Clinica Dermatologica - A.O.U. di Padova

Padua, Italy

U.O.C Ematologia 1 - IRCCS Fondazione Policlinico San Matteo

Pavia, Italy

IRCCS I.F.O. San Gallicano - UOSD Porfirie e Malattie Rare

Roma, Italy

Skin Cancer Center - IRCCS Istituto Dermopatico dell'Immacolata

Roma, Italy

U.O.C. Dermatologia - A.O.U. Senese

Siena, Italy

A.O.U. Città della Salute e della Scienza di Torino - S.C. Dermatologia U

Torino, Italy

A.O.U.I. di Verona - U.O.C. Ematologia

Verona, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06588868

Related Trials

A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

NCT070554771 location

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

NCT052963043 locations

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

NCT073562451 location

Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas

NCT059560411 location

Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

NCT070478851 location